There are three major endogenous cellular inhibitors that regulate PP2A activity: Inhibitor 2 of PP2A (I2PP2A or SET), CIP2A and PME1, all of which have been heavily implicated in tumor promotion and are overexpressed in many cancer types (30). The gene discussed is PPME1; the disease is cancer.